Biopharm Chemicals Co.,Ltd., the world-class leading pharmaceuticals and pharma foods under the standard of EU GMP PIC/S by Mr.Virapatna Thakolsri (left) Managing Director,joined hands in contract signing with Mr. Yoshihiro Miwa (right) , President & CEO of Kowa Company, Ltd. to officially launch LIVALO in Thailand distributed by Biopharm Chemicals Co.,Ltd. LIVALO has been the latest Anti- Cholesterol agent and the most safety statin with clinical proven in Japan.
BIOPHARM CHEMICALS AND KOWA COMPANY CONTRACT SIGNING CEREMONY FOR LIVALO
Mr.Sakesuk Kasemsuwan ,Marketing Director of Biopharm Chemicals Co.,Ltd., mentioned that the marketing plan for LIVALO product has been in line with Thailand’s changing population structure of which ratio of aged people has been increasing for 3 decades from 6.3 % of total population in 1980 and presently 11.8 % of total population in 2010. Not only focusing on baby boomers , LIVALO also covers the target group of urbanese professionals whose lifestyle has effected their health such as consuming high-fat food, working with stess and strain and less exercises leading to blood diseases , high blood pressure, heart disease, diabetes etc.
LIVALO, the latest Anti- Cholesterol agent , is produced by Kowa Company Ltd., a part of Kowa Group,Japan,which has been engaged in manufacturing and trading activities for 63 years of operation in the fields of pharmaceutical, life science and information technology, textiles, machinery and consumer products. The company operates in Japan, the US, and Europe. It is headquartered in Tokyo, Japan and employs around 2,123 people. The company recorded revenues of JPY 235,700 million (approximately US $ 2,357 million) in the fiscal year ended.Under the management of Mr. Yoshihiro Miwa , President & CEO,the company has achieved dramatical success, growth and reputation. Presently Kowa has four major R&D Centers and Kowa Research Institutes in Tokyo , Fuji Shiozuka,North Carolina in USA, and London in UK.
he mutual cooperation between Biopharm Chemicals Co.,Ltd and Kowa Company Ltd.represents the combination of Thai and Japanese companies’strength in medical science, research, innovation , manufacturing and marketing in the world-class standard and professional management.”
Press Release By:
บ.เบรนเอเซีย คอมมิวนิเคชั่น จก.
123 ประชาชื่น 11 , ถ.ประชาชื่น ,บางซื่อ ,กทม.10800
Tel : 02-911-3282 (Auto 5 Lines)
Mobile : 081-899-3599
Fax : 02-911-3208
Email : brainasiapr@hotmail.com
Press Release By:
Brainasiapr
BIOPHARM,BIOPHARM CHEMICALS,KOWA,LIVALO,pharma foods
Popularity: 8% [?]
Loading ...
